idiopathic pulmonary fibrosis

Incidence, outcomes and risk factors for neoplasms in explanted lungs
Manel El Andaloussi, Xavier Demant, Elodie Blanchard, Julie Macey, Hadrien Roze, Matthieu Rigaud, Jacques Jougon, Hugues Begueret, Chantal Raherison, Manuel Tunon De Lara, Claire Dromer

European Respiratory Journal Sep 2016, 48 (suppl 60) PA2534; DOI: 10.1183/13993003.congress-2016.PA2534
Correlation of composite physiologic index with 6-minute walk test variables in patients with idiopathic interstitial pneumonias
Keisuke Morikawa, Yasunori Imaoka, Hiroyuki Takemura, Shogo Inaba, Syunta Shimoda, Makoto Okada, Esteban Cesar Gabazza Sanabria, Osamu Hataji

European Respiratory Journal Sep 2016, 48 (suppl 60) PA2276; DOI: 10.1183/13993003.congress-2016.PA2276
Disease progression in early idiopathic pulmonary fibrosis: Insights from the Australian IPF registry
Helen Jo, Ian Glaspole, Yuben Moodley, Sally Chapman, Wendy Cooper, Samantha Ellis, Nicole Goh, Peter Hopkins, Greg Keir, Annabelle Mahar, Paul Reynolds, Haydn Walters, Christopher Zappala, Christopher Grainge, Heather Allan, Tamera Corte

European Respiratory Journal Sep 2016, 48 (suppl 60) PA2100; DOI: 10.1183/13993003.congress-2016.PA2100
A supportive care decision aid tool for idiopathic pulmonary fibrosis
Charles Sharp, Adrienne Edwards, Heather Lamb, Sorayya Alam, Nikki Jordan, Rachel Gunary, Patricia Meek, Ann Millar, Clare Kendall, Huzaifa Adamali

European Respiratory Journal Sep 2016, 48 (suppl 60) PA2102; DOI: 10.1183/13993003.congress-2016.PA2102
Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis
Hirotsugu Ohkubo, Mitsuaki Yagi, Yasuhiro Kondoh, Takeshi Johkoh, Hiroaki Arakawa, Akio Niimi, Hiroyuki Taniguchi

European Respiratory Journal Sep 2016, 48 (suppl 60) PA2098; DOI: 10.1183/13993003.congress-2016.PA2098
Efficacy of pirfenidone in idiopathic pulmonary fibrosis: A single center experience
Katleen Leceuvre, Els De Dycker, Tom Moerman, Jonas Yserbyt, Wim Wuyts

European Respiratory Journal Sep 2016, 48 (suppl 60) PA2088; DOI: 10.1183/13993003.congress-2016.PA2088
MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF alveolar macrophages
Eliza Tsitoura, Athol U. Wells, Chara Koutoulaki, Konstantinos Karagiannis, Ismini Lasithiotaki, Eirini Vasarmidi, Hiroe Sato, Demetrios A. Spandidos, Nikolaos M. Siafakas, Georgios Sourvinos, Katerina Antoniou

European Respiratory Journal Sep 2016, 48 (suppl 60) PA2094; DOI: 10.1183/13993003.congress-2016.PA2094
Clinical experience with nintedanib for the treatment of IPF in 80 cases
Maria Kontou, Velissaria Bousgou, Vasileios Tzilas, Evangelos Bouros, Stamatios Tsipilis, Anreas Granitsas, Evangelos Marozanes, George Dionelis, Nikolaos Koulouris, Demosthenes Bouros

European Respiratory Journal Sep 2016, 48 (suppl 60) PA2086; DOI: 10.1183/13993003.congress-2016.PA2086
Treg depletion reduces bleomycin-induced pulmonary fibrosis by inducing Th17 and other CD4+T cell subset responses in lung
Kaustav Chakraborty, Arindam Bhattacharyya

European Respiratory Journal Sep 2016, 48 (suppl 60) PA2095; DOI: 10.1183/13993003.congress-2016.PA2095
Survival from acute exacerbation of idiopathic pulmonary fibrosis with or without direct hemoperfusion with polymyxin B-immobilized fiber column: A retrospective analysis
Keiji Oishi, Keisuke Aoe, Yusuke Mimura, Yoriyuki Murata, Kenji Sakamoto, Wataru Koutoku, Tsuneo Matsumoto, Hiroshi Ueoka, Kazuto Mastunaga, Masafumi Yano

European Respiratory Journal Sep 2016, 48 (suppl 60) PA2101; DOI: 10.1183/13993003.congress-2016.PA2101

Main menu

User menu

Search

idiopathic pulmonary fibrosis

Pages

Contact us